Updates and Stories About Pre-Market Medicines Access

real world research

Expanded Access to Advanced Cell Therapies

December 16, 2021

A Recap of Ax-S Thursdays Session #1

February 17, 2021

Professional doctors and patients in a virtual environment

What Happened to Expanded Access to New Medicines?

November 16, 2020

Becoming Board Certified in Medical Affairs (BCMAS): The new standard in Pharma

January 13, 2020

FDA’s Project Facilitate fielded 161 compassionate use requests in first three months

November 20, 2019

Peter J. Pitts: Executive action could snuff medical research

October 10, 2019

Expediting Access to Rare Disease Therapies in Europe

October 8, 2019

Biosimilar Approvals And The BPCIA: Too Soon To Give Up

September 30, 2019

Three (BIG) things you didn’t know about Expanded Access to new medicines

August 28, 2019

Why I Launched the Expanded Access Summit

August 9, 2019

Your updates for the global forum on pre market medicines access

May 31, 2019

Announcement of Date and Location Change!

July 19, 2018

“Right To Try”: Big Impact or Big Sideshow?

May 30, 2018